Literature DB >> 18752577

Less severe bleeding in hemophilia B than in hemophilia A.

G D O Lowe, C A Ludlam.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18752577     DOI： 10.1111/j.1538-7836.2008.03126.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

1.  A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.

Authors:  Kathelijn Fischer; Maurice E Pouw; Daniel Lewandowski; Mart P Janssen; H Marijke van den Berg; Ben A van Hout
Journal:  Haematologica       Date:  2011-01-27       Impact factor: 9.941

2.  Factor IX and deep vein thrombosis.

Authors:  Gordon Lowe
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

3.  Outcome in moderate haemophilia.

Authors:  Ingrid den Uijl; Douwe Biesma; Diederick Grobbee; Kathelijn Fischer
Journal:  Blood Transfus       Date:  2012-11-20       Impact factor: 3.443

4.  Treatment of hemophilia B: focus on recombinant factor IX.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Cinzia Sissa; Carlo Bonfanti
Journal:  Biologics       Date:  2013-02-12

5.  Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX.

Authors:  Ki-Young Yoo; Soo-Young Jung; Sung-Ho Hwang; Su-Min Lee; Jong-Ho Park; Hyun-Ja Nam
Journal:  Blood Res       Date:  2018-03-27

6.  Comparison of Total Joint Replacement Rate Between Patients With Hemophilia A and Patients With Hemophilia B: A Population-Based and Retrospective Cohort Study.

Authors:  Wen-Ya Lin; Jiaan-Der Wang; Yu-Tse Tsan; Wei-Cheng Chan; Kwok-Man Tong; Shin-Tsu Chang; Yuan-Yang Cheng
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-13       Impact factor: 2.389

Review 7.  Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review.

Authors:  Samantha Pasca; Ezio Zanon
Journal:  Drug Des Devel Ther       Date:  2022-09-15       Impact factor: 4.319

8.  Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients.

Authors:  Agoritsa Varaklioti; Nick Kontodimopoulos; Olga Katsarou; Dimitris Niakas
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

9.  [Retrospectively analysis of the difference of bleeding frequency and hemophilic arthropathy between hemophilia A and hemophilia B patients].

Authors:  S X Wang; Y Guan; Y B Nie; H Y Li; B Y Sun; X Y Wang; R C Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.